Objectives: Stem cell factor (SCF) is considered as a commonly indispensable cytokine for proliferation of haematopoietic stem cells (HSCs), which is used in large dosages during ex vivo culture. The work presented here aimed to reduce the consumption of SCF by sustained release but still support cells proliferation and maintain the multipotency of HSCs.
| INTRODUCTION
Haematopoietic stem cells (HSCs) have attracted increasing attention over the past several decades because they play a critical role in the treatment of severe haematological diseases and cancers such as leukaemia, haemolytic anaemia and lymphoma. [1] [2] [3] Nowadays, cord blood (CB) is considered as a promising source of HSCs for cell transplantation, but the small volume of HSCs collected from a single donor has greatly restricted the clinical application. [4] [5] [6] [7] Indeed, HSCs grow in a specified niche, the so-called "haematopoietic niche,"
which has been identified to play an essential role in regulating behaviours of stem cell including quiescence, migration, proliferation and maturation. [8] [9] [10] [11] [12] Therefore, ex vivo expansion is a desirable strategy for donated HSCs to achieve sufficient cells by simulating this microenvironment. 13 These behaviours of HSCs are greatly influenced by cytokines during ex vivo culture. 14 Meanwhile, among numerous cytokines utilized for proliferation of HSCs, stem cell factor (SCF) has been identified to serve as guidance cues that direct HSCs to the niche, and it is conducive to HSC maintenance. 15 It has been emphasized that the insufficient supplement of SCF would result in impeding proliferation of
HSCs, but the excessive amount of SCF also leads to loss of stemness. 16 Additionally, SCF stimulates the proliferation of myeloid, erythroid and lymphoid progenitors and acts synergistically with colony-stimulating factors. 17 In spite of widespread usage of SCF during ex vivo culture of HSCs, nevertheless, an optimal feeding strategy has not yet been defined. In conventional culture conditions, SCF was usually supplemented continually with the combination of thrombopoietin (TPO) and Flt3-Ligand (Flt-3) during the whole culture process. 18 However, SCF is an extraordinarily expensive and efficient cytokines and has low service efficiency in conventional culture conditions. Previous research has reported that SCF exerts its activity at the early stages of
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haematopoiesis. 19 Thus, new feeding strategies of SCF with high efficiency are urgent to be developed. More recently, SCF was covalently immobilized on polymeric substrate materials such as poly (ethylene glycol) and gelatin. Although the consumption of SCF was reduced and selectivity for maintaining primitive HSCs was improved, proliferation capacity of cells decreased dramatically. 20 Therefore, we aimed to develop a strategy to reduce consumption of SCF without affecting the proliferation of HSCs. To the best of our knowledge, there are few reports on in situ release of SCF from substrate materials. In this study, SCF is physically encapsulated within a porous scaffold and released via a straightforward process of diffusion, and the high bioactivity of SCF may be remained at the same time.
It has been proven that the physicochemical property of microenvironment is also a determinant for HSCs behaviours. [21] [22] [23] A lot of efforts have been turned towards developing two-and three-dimensional biomaterials such as microspheres, films, scaffolds and hydrogels for proliferation or differentiation of HSCs. [24] [25] [26] [27] Among them, hydrogels are considered as promising candidates for cells culture due to their adjustable properties and high water content, providing an artificial microenvironment similar to the native Excetral Cellular Matrix (ECM). [28] [29] [30] However, bare hydrogels are rarely utilized to load cytokines or growth factors, because their loose crosslinked networks usually result in a relatively rapid release rate. For instance, most of recombinant human interleukin-2 (IL-2) encapsulated in dextran hydrogels was released within initial 2 days. 31 In the last decade, the double network (DN) hydrogel, which generally consists in the combination of a fragile network with a ductile one, has exhibited a higher mechanical strength. 32 Moreover, the DN hydrogel with a tighter inner structure has been utilized for sustained release of peptides, proteins and drugs, which could significantly reduce release rate and undesired leakage. 33 Thus, SCF encapsulated within DN hydrogels may achieve a suitable release for proliferation of HSCs.
Herein, we encapsulated SCF within a hyaluronic acid/gelatin double network (HGDN) hydrogel for ex vivo culture of CD34 + cells.
Hyaluronic acid and gelatin were modified with a photo-crosslinkable segment, and the HGDN hydrogel was fabricated via a two-step photo-crosslinking process ( Figure 1 ). SCF was physically encapsulated within the hydrogel prior to the second photo-crosslinking, and its release behaviour was further evaluated by ELISA kit. One parameter investigated was the impact of SCF released from hydrogels on survival of CD34 + cells. Moreover, after the end of culture, CD34 + cells were harvested to evaluate the multipotency. 
| MATERIALS AND METHODS

| Hydrogel preparation
Methacrylated hyaluronic acid (HAMA) and methacrylated gelatin (GelMA) were synthesized by the esterification of sodium hyaluronate and gelatin with methacrylic anhydride, respectively.
Meanwhile, a high-efficient photo-initiator, lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP), was also synthesized (see Figure   S1 ). The HAMA hydrogel was prepared by pouring pre-gel solution of 3 wt% HAMA and 0.1 wt% LAP into a special round mold, and then irradiated by ultraviolet light (365 nm, 6 mW/cm 2 ) for 30 seconds.
The GelMA hydrogel was prepared by dissolving 5 wt% GelMA and 0.1 wt% LAP in phosphate buffer solution (PBS) at 37°C in the same manner. To prepare the HGDN hydrogel, the as-prepared HAMA F I G U R E 1 A schematic representation of the SCF-loaded hyaluronic acid/gelatin double network (HGDN) hydrogel fabricated via a two-step photo-crosslinking process. SCF was encapsulated within the hyaluronic acid/gelatin double network (HGDN) hydrogel to achieve a sustained release and support proliferation of haematopoietic stem cells (HSCs)
hydrogel as the first network was immersed in solution containing 5
wt% GelMA and 0.1 wt% LAP, and placed in a shaking bed at 37°C for 2 days to reach swelling equilibrium. Finally, the HGDN hydrogel was fabricated by UV light again for 30 seconds.
| Hydrogel characterization
The microstructure of hydrogels was characterized by scanning electron microscope (SEM; S-3400N, Hitachi, Tokyo, Japan). Freeze-dried samples were sputtered with a thin layer of gold and imaged with an accelerating voltage of 15 kV.
The mechanical properties of hydrogels were determined by using a mechanical testing system (TCS-2000, Gothch, Dongguan, China).
Samples were prepared with a dimension of 10 mm × 5.0 mm (diameter × thickness), and then they were compressed with a crosshead at a rate of 1 mm/min. The elastic modulus was calculated as the slope of the linear region (initial 10% strain) of the stress-strain curves.
Swelling behaviour of hydrogels was measured by weight. The dried hydrogel was weighed (m d ) and immersed in PBS at room temperature. After each predetermined time interval, the excess PBS on surface was removed and the swelling hydrogel was weighed (m s ).
Swelling ratio (SR) of hydrogel was calculated as follows:
| Release profile of SCF
To study release profile of SCF from a single network (SN) hydrogel, SCF (50 ng/mL) was directly mixed into pre-gel solution to prepare SCFloaded hydrogels. For the SCF-loaded HGDN hydrogel, SCF (500 ng/ mL) was added to the pre-gel solution in the formation of second network ( Figure 1 ), and the SCF-loaded HGDN hydrogel was prepared by UV light irradiation again. Here, the concentration of SCF in the HGDN hydrogel was fixed at 50 ng/mL. Then, hydrogels were immersed in PBS in a shaking bed at 37°C with an oscillation frequency of 80 rpm.
After each predetermined time interval, a certain amount of supernatant was taken out and an equal volume of PBS was supplemented.
The percentage of SCF released from hydrogels was determined using a sandwich ELISA kit according to the manufacturer's instructions.
| Biocompatibility of hydrogels
The biocompatibility of hydrogels was evaluated by a direct contact between MNCs and hydrogels. 26 In brief, MNCs were seeded in plates 
| Establishment of culture conditions
To study the SCF-loaded HGDN hydrogel for cell culture, four culture conditions were designed. 
| Flow cytometry
| Colony-forming unit assay
| Statistical analysis
All values were presented as mean ± standard deviation. For ex vivo experiments, average values were determined from at least 3 independent samples. Statistical significance was evaluated by ANOVA using GraphPad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA).
P < .05 was considered to be statistically significant.
| Hydrogel characterization
The hydrogels were successfully synthesized, which was confirmed by 1 H-NMR spectrum ( Figure S1 ). The micromorphology of the HAMA hydrogel, GelMA hydrogel and HGDN hydrogel were characterized by SEM, as shown in Figure 2 . All samples showed a highly ordered porous structure with the average pore size of 62.4 ± 2.8, 31.8 ± 3.7 and 26.7 ± 2.5 μm for the HAMA hydrogel, GelMA hydrogel and HGDN hydrogel, respectively. The porous structure of hydrogels could provide sufficient surface area for nutrient exchange and the growth of encapsulated cells.
The mechanical property of hydrogels was evaluated by uniaxial compression test ( Figure 3A) . From stress-strain curves, we found that all hydrogels exhibited a typical characteristic of viscoelastic materials.
For SN hydrogels, the compressive modulus and failure stress of the HAMA hydrogel were both higher than those of the GelMA hydrogel even though the GelMA hydrogel contained higher polymer composition. Nevertheless, the GelMA hydrogel was tougher than the HAMA hydrogel, breaking at 75.12% ± 2.01% vs 65.45% ± 1.12%, respectively. Thus, to prepare a DN hydrogel, the stiffer HAMA was chosen as the first network, and the GelMA was used as the second one. The results showed that the HGDN hydrogel had significantly higher compressive modulus and failure stress.
In this study, the swelling behaviour of hydrogels was evaluated ( Figure 3C ). It could be clearly seen that all hydrogels possessed high ability of water absorption, but the HGDN hydrogel had a relatively lower SR.
| Release profiles of SCF from hydrogels
SCF was physically encapsulated within hydrogels via a straightforward process, and SCF released from hydrogels was determined using ELISA assay as shown in Figure 3D . The release of SCF from the HGDN hydrogel was much slower than that from HAMA hydrogel and GelMA hydrogel, and the cumulative release amount of SCF from the HAMA hydrogel, GelMA hydrogel and HGDN hydrogel was 92.75% ± 1.86%, 82.53% ± 2.16% and 62.95% ± 2.06% within the first 2 days, respectively. Additionally, the release of SCF encapsulated within the HGDN hydrogel could sustain over 6 days, which could exactly meet the requirement of HSCs.
| Biocompatibility of hydrogels
The biocompatibility was determined by seeding MNCs on hydrogels and plates without any cytokines and culturing for 14 days. It could be clearly seen that cells maintained a high cell viability (>90%) for all experimental groups ( Figure 4A ). An overall down-regulation trend could be found for harvested MNCs, but there was no statistical significance compared to the control ( Figure 4B) . Therefore, the HGDN hydrogel showed a good biocompatibility, which was a potential biomaterial for ex vivo culture of CD34 + cells. 
| Proliferation and phenotype of CD34 + cells within the SCF-loaded HGDN hydrogel
| DISCUSSION
Haematopoietic stem cells are capable of long-term self-renewal in the native niche, while they are easily differentiated during ex vivo culture. 21 Although a variety of conditions have been developed for ex vivo culture of HSCs, the benefits obtained are limited, and long-term maintenance of HSCs with high self-renewal capacity still remains a big challenge. 34 Many reports have highlighted that the artificial environment was insufficient for preserving HSCs, thus a series of concentrations and combinations of cytokines have been tested to ex was calculated on days 7 and 14 (P < .05; n = 3)
The number of colony-forming unit (CFUs) granulocytes-macrophage colony-forming unit (CFU-GM), granulocyte-erythroid-macrophage-megakaryocytes colony-forming unit (CFU-GEMM), erythroid burst-forming unit (BFU-E) and total CFU) resulting from 500 CD34 + cells re-isolated from expanded cells under 4 conditions for 14 days (P < .05; n = 3) vivo culture HSC. 35 However, all attempts could not really mimic the complicated microenvironment of the niche and could not well support proliferation of HSCs. SCF has been identified to be a critical component responsible for survival and maintenance of HSCs in the niche. [36] [37] [38] However, SCF is a quite expensive and efficient cytokine and the high cost associated with its continuous supplement in the conventional culture is detrimental for stem cell engineering. Thus, we look for a new feeding strategy of SCF to reduce the consumption of SCF during ex vivo culture.
Our prior research has shown that the initial 4 days were the critical period for SCF to stimulate the proliferation of HSCs. 39 Thus, we attempted to use hydrogel as the carrier to load SCF and achieve in situ release of SCF. Nevertheless, common hydrogels were hardly applied to sustained release of cytokines, owing to the quick diffusion of cytokines. From the release profiles of SCF, the experimental data also affirmed that the encapsulated SCF could be released from the HAMA hydrogel and GelMA hydrogel within 3 days, which was insufficient for proliferation of HSCs. Comparatively, based on the HGDN hydrogel, encapsulated SCF exhibited a much lower release rate and could continually release for more than 6 days, exactly meeting the requirement of HSCs. The decreased release rate may be resulted from the DN structure with a smaller pore size and higher polymer content with a relatively stronger polyion complexation.
In addition, hyaluronic acid and gelatin are the main components of the HGDN hydrogel, and they have been considered as desirable candidates for hydrogels. Hyaluronic acid is no antigenic, eliciting no inflammatory or foreign-body reaction, and gelatin, a degradation product of collagen, is rich in peptide sequences, such as RGD, which have an advantageous effect on the proliferation of HSCs. [40] [41] [42] The new microenvironment constructed by the HGDN hydrogel was a porous morphology, providing sufficient space for cells migration.
Besides, the HGDN hydrogel provides a relatively higher compressive modulus. Although there was no agreement on optimal stiffness of biomaterials for HSC culture, it was reported that HSCs prefer a stiffer substance materials (12.2-30.4 kPa), where the proliferation and migration of cells were promoted.
43,44
Introduction of SCF will significantly affect the balance between proliferation and differentiation of HSCs. In most cases, it is a con- HSCs cultured in plates or the HGDN hydrogels showed equivalent increases in proliferation after 2 weeks, but the SCF-loaded HGDN hydrogels was demonstrated to be more favourable for maintenance of multipotency, and it was important to be noted that the former condition (Condition II) required a significantly greater SCF (SCF added to medium for repeated medium changes) total. Therefore, the SCF-loaded HGDN hydrogel provided a preferable microenvironment for HSCs.
| CONCLUSIONS
We have developed a SCF-loaded HGDN hydrogel as a threedimensional biomimetic scaffold for ex vivo culture of CD34 + cells. 
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